CRVO

CervoMed Inc. · NASDAQ

Sector Commercial Services
Industry Miscellaneous Commercial Services
Website cervomed.com
Employees(FY) 4
ISIN US15713L1098

Performance

-3.71%

-20.22%

+17.67%

+276.17%

+210.26%

YTD

-63.26%

Profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.

Advanced Technical Analysis

Technical Analysis of CRVO 2025-06-16

The Moving Average Score of 8 indicates a strong bearish sentiment, while the Oscillators Score of 45 suggests a neutral stance. However, the overall Technical Score of 26 reinforces a bearish outlook, indicating that the stock is currently facing significant downward pressure.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CRVO

Stock Rank

Recent News & Updates

2025-04-01 19:00
Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD 2025(Globenewswire)
2025-03-31 02:34
Biotech Stocks Q1 2025 Recap: Winners And Underperformers(Seekingalpha)
2025-03-24 20:00
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD )(Globenewswire)
2025-03-21 23:00
Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings(Seekingalpha)
2025-03-21 14:55
CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats(Seekingalpha)
2025-03-19 04:27
Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts?(Yahoo Finance)
2025-03-17 16:48
CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now(Yahoo Finance)
2025-03-16 20:00
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates(Globenewswire)
2025-03-16 19:28
Why CervoMed Inc. (CRVO) Soared Last Week?(Yahoo Finance)
2025-03-13 23:25
CervoMed upgraded to Buy at JonesResearch on more confidence in DLB program(Yahoo Finance)
2025-03-10 04:05
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies(Globenewswire)
2025-02-19 01:09
Why CervoMed (CRVO) Is Advancing Today(Yahoo Finance)
2025-01-30 19:00
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference(Globenewswire)
2025-01-28 19:00
CervoMed to Present at the 8th International Lewy Body Dementia Conference(Globenewswire)

Page 1 of 1

previousnext

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.

CRVO

Performance

Profile

Technical Analysis of CRVO 2025-06-16

Stock Analysis of CRVO

Recent News & Updates

Notifications

Upgrade to Pro

Pro Features Include: